Mutations in the small heterodimer partner gene increase morbidity risk in Japanese type 2 diabetes patients

Mayumi Enya1, Yukio Horikawa, Eiji Kuroda

  • 1Department of Diabetes and Endocrinology Division of Molecule and Structure Gifu University School of Medicine, Gifu.

Human Mutation
|September 11, 2008
PubMed

Insights

Small heterodimer partner (SHP) gene mutations linked to childhood obesity increase the risk of developing type 2 diabetes later in life for Japanese individuals. These SHP mutations reduce protein function, impacting diabetes susceptibility.

Area of Science:

  • Genetics
  • Endocrinology
  • Metabolic Diseases

Background:

  • Mutations in the small heterodimer partner (SHP) gene (NR0B2) are linked to high birth weight and mild childhood obesity in Japanese populations.
  • SHP gene mutations are hypothesized to contribute to adult-onset obesity and insulin resistance syndrome, potentially leading to type 2 diabetes.

Purpose of the Study:

  • To determine the prevalence of SHP gene mutations in Japanese individuals with and without type 2 diabetes mellitus.
  • To evaluate the functional impact of identified SHP mutations on protein activity.

Main Methods:

  • Direct sequencing of SHP gene exons and flanking regions was performed on 805 patients with type 2 diabetes and 752 non-diabetic controls.
  • Functional assays were conducted to assess the activity of mutant SHP proteins.

Main Results:

  • Fifteen distinct SHP mutations, including six novel ones, were identified in 44 subjects.
  • Nine of the identified mutations exhibited significantly reduced protein activity.
  • Mutations with reduced activity were more frequent in the diabetic group (2.4%) compared to the control group (0.8%), with a statistically significant difference (P=0.029).

Conclusions:

  • SHP gene mutations, initially associated with mild childhood obesity, are implicated in increased susceptibility to type 2 diabetes in Japanese adults.
  • Reduced functional activity of SHP mutations appears to be a key factor in this increased diabetes risk.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...